Latest
Sources
Trade Ideas
Speakers
Sign in
Go
The European Commission Approves Novo Nordisk's 7.2 mg Once‑Weekly Maintenance Dose Of Wegovy (Semaglutide Injection) For Obese Adults
Original source ↗
| February 17, 2026 at 11:17 UTC |
Finnhub - NVO
No analysis available.
Trade Ideas
Ticker
Direction
Speaker
Thesis
Time
NVO
NONE
Finnhub News
—
—